Currently, lung cancer screening programs are targeted primarily towards older individuals with a history of smoking. Undoubtedly, smoking is the leading risk factors but at the same time it is also true…
Simple Urine Test Could Identify Lung Cancer at Early Stage
Most lung cancer cases are identified at advanced stages and thus, complicate the treatment and reduce survival chances. Early identification of lung cancer is helpful in saving more lives as the disease…
Merck-Kelun Lung Cancer Drug Outperforms Keytruda in Trial
According to Phase 3 study results, Merck-Kelun combo can reduce the risk of tumor progression by 65% in patients with lung cancer. The study has been conducted in China and is the…
India’s First 7-Minute NSCLC Shot Launched Costing ₹3.7 Lakh Per Dose
India has taken a major step towards lung cancer treatment with launch of a new seven-minute NSCLC injection. Roche Pharma India has introduced a new drug called Tecentriq and is designed to…
Study Finds that Many NSCLC Patients Never Receive Treatment
According to a new study, an alarming number of patients with advanced lung cancer are not receiving treatment, despite many advances over recent decades. These new findings are from a large population-based…
Taletrectinib for ROS1+ NSCLC Subtype, NCCN Guidelines
The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines for Central Nervous System Cancers to include taletrectinib. Taletrectinib acts as a next-generation targeted therapy for ROS1-positive non-small cell lung…
Identifying Lung Cancer Cough For Early Diagnosis And Treatment
When abnormal cells in your lungs start to grow uncontrollably, this is the condition of lung cancer. Such cells form a mass called as tumor. There are two types of lung cancer:…
Study: Pesticide Exposure in Fruits and Vegetables Increase Lung Cancer Risk
Healthy Diets and Lung Cancer? A surprising new study has suggested that eating a healthy diet might be linked to higher risk of lung cancer in young non-smokers. Yes, you read that…